Have a personal or library account? Click to login
Ubiquinone Plasma Levels are Correlated with Brain Natriuretic Peptide Plasma Levels in Patients with Chronic Heart Failure: The Potential of Coenzyme Q10 Combined Therapy Cover

Ubiquinone Plasma Levels are Correlated with Brain Natriuretic Peptide Plasma Levels in Patients with Chronic Heart Failure: The Potential of Coenzyme Q10 Combined Therapy

Open Access
|Jul 2018

References

  1. 1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics 2014 update: a report from the American Heart Association. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2014; 129: 280-292.
  2. 2. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6–13.10.1016/0735-1097(93)90455-A
  3. 3. McMurray JJ, Adamopuulus S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Deloped in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787–847.10.1093/eurheartj/ehs104
  4. 4. Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2013; 128: 240-327.10.1161/CIR.0b013e31829e8776
  5. 5. Aronov DM. Importance of coenzyme Q10 in cardiology. Russian Medical Journal, 2007; 15: 1484-1488.
  6. 6. Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. Am J Clin Nutr 2013; 97: 268–275.10.3945/ajcn.112.040741
  7. 7. Mortensen SA. Coenzyme Q10: will this natural substance become a guideline-directed adjunctive therapy in heart failure? JACC Heart Fail 2015; 3:270-271.10.1016/j.jchf.2014.12.006
  8. 8. Miles MV, Horn PS, Tang PH, et al. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. AJ Clin Chim Acta 2004; 347: 139-144.10.1016/j.cccn.2004.04.003
  9. 9. Medvedev OS, Kalenikova EI, Gorodetzkaya EA, et al. Coenzyme Q10 in cardiology practice – theoretical bases and clinical studies results. Russian Medical Journal, 2009; 17: 1177-1181.
  10. 10. R. Ferrari, L. Agnoletti, L. Comini, G. et al. Oxidative stress during myocardial ischemia and heart failure, Eur Heart J 1998; 19:2–11.
  11. 11. Sarah L. Molyneux, Christopher M, et al. Coenzyme Q10 An Independent Predictor of Mortality in Chronic Heart Failure Christchurch, New Zealand. J Am Coll Caqrdiol 2008; 52: 1435-1441.
  12. 12. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007; 100: 460–473.10.1161/01.RES.0000258450.44413.96
  13. 13. Ponikowski P, Voors AA, Anker SD et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016, 20.10.1093/eurheartj/ehw128
  14. 14. Berezin AE. Biological markers in chronic heart failure: hopes, reality, perspectives. Serceva nedostatnist 2013; 1:5-15.
  15. 15. Tsutamoto T. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 199; 20: 1799-1807.10.1053/euhj.1999.1746
  16. 16. Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q 10 illuminated by meta-analyses of clinical trials. Mol Aspects Med 1997; 18: 159–168.10.1016/S0098-2997(97)00042-3
  17. 17. Sander S, Coleman CI, Patel AA, et al. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail 2006; 12: 464–472.10.1016/j.cardfail.2006.03.00716911914
  18. 18. Judy WV, Hall JH, Toth PD, et al. Double blind-double crossover study of coenzyme Q10 in heart failure, in: Biomedical and Clinical Aspects of Coenzyme Q, Vol. 5. K. Folkers and Y. Yamamura, eds, Elsevier, Amsterdam 1986, pp. 315–323.
  19. 19. Munkholm H, Hansen HHT, Rasmussen K. Coenzyme Q10 treatment in serious heart failure. Ann Intern Med 1999; 9: 285–289.10.1002/biof.5520090225
  20. 20. Wolsk E, Claggett B, Pfeffer MA, et al. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. J Am Heart Assoc. 2017; 6: 43-47.10.1161/JAHA.116.004743566914628554908
  21. 21. Edlund PO. Determination of coenzyme Q10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 1988; 425: 87–97.10.1016/0378-4347(88)80009-4
  22. 22. Rosenfeldt FL, Haas SJ, Krum H, et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens 2007; 21:297-306.10.1038/sj.jhh.1002138
  23. 23. Gorokhova SG, Sizova ZM. Pharmacotherapy of chronic heart failure in ambulatory practice. Physician’s workbook. Medpraktika-M 2008; pp.85.
  24. 24. Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014; 2:641–649.10.1016/j.jchf.2014.06.008
  25. 25. Keogh A, Fenton S, Leslie C, et al. Randomized doubleblind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure. Heart Lung Circ. 2003; 12:135–141.10.1046/j.1443-9506.2003.00189.x
  26. 26. DiNicolantonio JJ, Bhutani J, McCarty MF, et al. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart 2015; 2: 32-36.10.1136/openhrt-2015-000326
  27. 27. Alehagen U, Johansson P, Bjornstedt M, et al. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized doubleblind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol. 2013; 167:1860-1866.10.1016/j.ijcard.2012.04.156
  28. 28. Sizova ZM, Farafoniva TN, Medvedev OS, et al. Possibilities of different doses coenzyme Q10 administration in patients with chronic heart failure. Heart failure 2010; 11: 218-222.
  29. 29. Tokareva OG, Kharitonova EV, Mareev VY, et al. Vliyanie koenzima Q10 v sostave standartnoj terapii bolnyx xronicheskoj serdechnoj nedostatochnostyu na plazmennye urovni mozgovogo natrijureticheskogo peptida. Zhurnal Serdechnaya Nedostatochnost 2014; 850: 232–237.
  30. 30. Jankowski J, Korzeniowska K, Cieslewicz A, et al. Coenzyme Q10 - A new player in the treatment of heart failure? Pharmacol Rep 2016; 68: 1015-1019.10.1016/j.pharep.2016.05.012
  31. 31. Lampertico M, Comis S. Italian multicenter study on the efficacy and safety of coenzyme Q10 as adjuvant therapy in heart failure. Clin Investig. 1993; 71: 129-133.10.1007/BF00226853
  32. 32. Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. Am J Clin Nutr 2013; 97: 268-75.10.3945/ajcn.112.040741
  33. 33. Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig. 1993; 71: 134–136.10.1007/BF00226854
  34. 34. Crane FL, Hatefi Y, Lester RL, et al. Isolation of a quinone from beef heart mitochondria. Biochim Biophys Acta 1957; 25: 220–1.10.1016/0006-3002(57)90457-2
  35. 35. Mellors A, Tappel AL. The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. J Biol Chem 1966; 241: 4353–4356.10.1016/S0021-9258(18)99728-0
DOI: https://doi.org/10.2478/sjecr-2018-0012 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 141 - 149
Submitted on: Apr 22, 2018
Accepted on: Apr 24, 2018
Published on: Jul 17, 2018
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Zh.M. Sizova, V.L. Zakharova, K.A. Alibeyli, O.S. Medvedev, E.V. Shikh, S.B. Bolevich, S.S. Bolevich, S.I. Vorobyev, S.V. Votrin, V.V. Padalko, A.A. Novikov, I.A. Omarov, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.